# FDA recall D-0724-2026

> **Rising Pharma Holding, Inc.** · Class II · drug recall initiated 2026-07-13.

## Product

Rising, Cyproheptadine Hydrochloride Syrup, 2mg/5 mL, 473 mL (ONE PINT), Rx only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ, Manufactured by: Lyne Laboratories, Inc., Brockton, MA. NDC 64980-504-48.

## Reason for recall

Presence of Precipitate: medication was crystallizing and particles floating in the bottle

## Distribution

Nationwide U.S.A.

## Key facts

- **Recall number:** D-0724-2026
- **Recalling firm:** Rising Pharma Holding, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2026-07-13
- **Report date:** 2026-07-29

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Brunswick, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0724-2026

## Citation

> AI Analytics. FDA recall D-0724-2026. Retrieved 2026-09-02 from https://api.ai-analytics.org/recall/D-0724-2026. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*